Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2010
Polo-like kinase 1 is a therapeutic target in high-risk neuroblastomaSandra Ackermann, Felix Goeser, Johannes H Schulte, et al.
BMC Cancer|November 20, 2014
FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastomaSandra Ackermann, Hayriye Kocak, Barbara Hero, et al.
Plos One|January 7, 2014
BAIAP2 is related to emotional modulation of human memory strengthGediminas Luksys, Sandra Ackermann, David Coynel, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 23, 2015
Sex-dependent dissociation between emotional appraisal and memory: a large-scale behavioral and fMRI studyKlara Spalek, Matthias Fastenrath, Sandra Ackermann, et al.
Cell & Bioscience|September 24, 2022
Reliable assessment of telomere maintenance mechanisms in neuroblastomaAlina Meeser, Christoph Bartenhagen, Lisa Werr, et al.
Molecular Oncology|November 25, 2015
Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastomaFakhera Ikram, Sandra Ackermann, Yvonne Kahlert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastomaJohannes H Schulte, Hagen S Bachmann, Bent Brockmeyer, et al.
Oncotarget|December 31, 2016
The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma modelsKristian W Pajtler, Natalie Sadowski, Sandra Ackermann, et al.
Pageof 3